When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?

Nat Clin Pract Nephrol. 2007 May;3(5):236-7. doi: 10.1038/ncpneph0468.
No abstract available

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Azathioprine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Methotrexate / therapeutic use
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Secondary Prevention
  • Vasculitis / drug therapy*
  • Vasculitis / immunology*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Azathioprine
  • Methotrexate